“…The gene maps to human chromosome 22q11.2, and changes in this gene, due to either a point mutation or a deletion of part of chromosome 22 encompassing TBX1 , are considered to be responsible for many of the features of DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS), a common congenital disorder characterized by neural‐crest‐related developmental defects. In the literature, 22q11.2 deletions have been also found to recur in patients with typical DGS/VCFS clinical features in association with hemifacial microsomia and microtia (Digilio et al., ; Dos Santos et al., ; Lafay‐Cousin et al., ; Spineli‐Silva, Bispo, Gil‐da‐Silva‐Lopes, & Vieira, ; Torti, Braddock, Bernreuter, & Batanian, ; Xu, Fan, & Siu, ), suggesting possible OAVS candidate genes in this segment. In view of these findings, TBX1 variant p.(Pro86Leu) likely represents the major determinant of the OAVS phenotype in the present patient, and the gene within 22q11.2 chromosome responsible for the OAVS features observed in patients with 22q11.2 deletion.…”